Skip to content

Clinical trials

Phase 2 Lymphoma, Non-Hodgkin trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Non-Hodgkin Phase: Phase 2 Country / region: Netherlands Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20081
20141
20182
20192
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actuate Therapeutics Inc.1
Bayer1
Bristol-Myers Squibb1
Celgene1
Genmab1
German High-Grade Non-Hodgkin's Lymphoma Study Group1
Hoffmann-La Roche1
Miltenyi Biomedicine GmbH1
Novartis Pharmaceuticals1
Stichting Hemato-Oncologie voor Volwassenen Nederland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Non-Hodgkin10
Lymphoma, Large B-Cell, Diffuse5
Lymphoma3
Burkitt Lymphoma2
Lymphoma, B-Cell2
Lymphoma, Follicular2
Neoplasms2
Recurrence2
Bone Neoplasms1
Breast Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.